Angle Health hits $2.7B valuation with $200M Series C

Health insurance startup Angle Health announced Friday that it raised a $200 million Series C, alongside a $400 million tender offer, at a $2.7 billion valuation — a notable round for a company founded in 2019 and not focused on AI agents. The round was led by Vitruvian Partners, with participation from Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital, and Y Combinator. The tender offer lets employees cash out some of their shares, the company told TechCrunch, and Angle expects the round to close later this month.

Angle Health, a winter 2020 Y Combinator alum, helps small businesses obtain and manage “level-funded health plans” — plans that sit between fully insured and self-funded coverage. In fully insured plans, the carrier takes on all the risk, making them more expensive but predictable in cost; in self-funded plans, the company covers expenses directly and costs can be unpredictable. Level-funded plans let businesses make predictable payments to carriers while remaining insured against higher-than-expected costs, with the potential to get back a share of the surplus if expenses stay low.

Angle says these plans can make health insurance more affordable for small businesses. It describes itself as an AI-powered platform that helps small businesses choose and manage plans, integrating with payroll and HR systems. The startup says it serves more than 5,000 businesses and is profitable.

Why it matters

A profitable, decade-old health-insurance startup raising at $2.7 billion shows investors are still funding durable, non-AI-agent business models when the underlying numbers hold up — even in a market currently dominated by AI-agent fundraising.